Your Safety, Our Priority

Rocky Mountain’s highly tenured team of medical professionals have strong foundations in medical information, pharmacovigilance, and quality monitoring for continuous improvement. 

Our skilled US-based pharmacists are empathetic and responsive, and all interactions are non-scripted and conversational. We’re here to help you navigate and demystify the regulatory landscape. Whether you are bringing a new product to market or need custom solutions, we are here to help!

ISO 9001:2015 Certification was issued to Rocky Mountain Poison & Drug Safety through PRI Certification with the scope of RMDC (Rocky Mountain Drug Center) contact center, which includes Pharmaceutical Medical Information (MI), Product Complaints (PCs) and Adverse Event (AEs). Not only does this certification increase our Drug Center’s contact center confidence in providing services with efficiency that can be trusted, but our clients can also be assured that we have a transparent and robust quality management system to support their needs.
Access our certification here.

Surveillance Systems and Methods

Rocky Mountain’s postmarketing surveillance model is comprised of various data sources and methodological approaches, ensuring the most complete and representative information is provided. We optimize the therapeutic potential of pharmaceutical products by describing their real-world risks and benefits. "Rocky Mountain Poison & Drug Safety data are relied on by the US FDA and dozens of the top 100 Pharmaceutical Companies."

Optimize Scientific Communication and Credibility

Rocky Mountain Poison & Drug Safety helps you enhance scientific credibility, support effective communication and prepare materials both in the pre-marketing and post-approval stages. Maximize the impact of your research by using our strong information management capabilities.

Bridging Science, Compliance and Safety

Rocky Mountain Poison & Drug Safety offers a variety of regulatory services, during product development, as well as in peri- and postmarketing phases. During product development we can help you navigate the complex regulatory landscape, ensure compliance and facilitate a smooth regulatory approval process.

Peri- and postmarketing, we help you maintain regulatory compliance, support risk management efforts and ultimately prioritize patient safety in the real-world use of pharmaceutical drugs and products. We bridge the gap between scientific knowledge, regulatory compliance and consumer safety, ultimately benefiting both the industry and consumers.

Our Expertise Streamlines Your Product's Journey

We evaluate drugs for poisoning treatment applications and orphan drug indications that involve multi-center operations, study management, data collection, data management, data analysis and reporting.

We have helped several drug companies to develop antidotes for poisonings in the US, including:

CroFab − North American crotaline snake envenomation

DigiFab − cardiac glycoside intoxications

Antizol − toxic alcohol (methanol & ethylene glycol) intoxications

Acetadote – acetaminophen intoxications

Radiogardase − thallium and radiocesium exposures

Cyanokit − cyanide exposures

The RADARS® (Researched Abuse Diversion and Addiction-Related Surveillance) System is an innovative model for post-marketing and public health surveillance for abuse, misuse, and diversion of prescription drugs.

No single data source can provide complete and representative information about a group – multiple data sources strengthen the credibility of findings, reduce the risk of false interpretations, and provide a more complete and comprehensive perspective of the study question.

Learn more about the RADARS System